X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $560 thousand versus the consensus estimate of $1.69 million.

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.